Alavi J - Search Results

1

Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): the expanded access protocol experience at the University of Pennsylvania.

Veronese ML, Algazy K, Bearn L, Eaby B, Alavi J, Evans T, Stevenson JP, Shults J. Veronese ML, et al. Among authors: alavi j. Cancer Invest. 2005;23(4):296-302. doi: 10.1081/cnv-61528. Cancer Invest. 2005. PMID: 16100941 Clinical Trial.

2

Clinical implications of learned food aversions in patients with cancer treated with chemotherapy or radiation therapy.

Mattes RD, Curran WJ Jr, Alavi J, Powlis W, Whittington R. Mattes RD, et al. Among authors: alavi j. Cancer. 1992 Jul 1;70(1):192-200. doi: 10.1002/1097-0142(19920701)70:1<192::aid-cncr2820700130>3.0.co;2-g. Cancer. 1992. PMID: 1606541 Clinical Trial.

3

Positron emission tomography in patients with glioma. A predictor of prognosis.

Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M. Alavi JB, et al. Among authors: alavi a. Cancer. 1988 Sep 15;62(6):1074-8. doi: 10.1002/1097-0142(19880915)62:6<1074::aid-cncr2820620609>3.0.co;2-h. Cancer. 1988. PMID: 3261622

4

Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas.

Balmaceda C, Peereboom D, Pannullo S, Cheung YK, Fisher PG, Alavi J, Sisti M, Chen J, Fine RL. Balmaceda C, et al. Among authors: alavi j. Cancer. 2008 Mar 1;112(5):1139-46. doi: 10.1002/cncr.23167. Cancer. 2008. PMID: 18246536 Free article. Clinical Trial.

5

Detection of unsuspected recurrent lymphoma with fluorodeoxyglucose-positron emission tomographic imaging after induction chemotherapy: a case study.

Alavi JB, Bénard F, Alavi A. Alavi JB, et al. Among authors: alavi a. Am J Clin Oncol. 1998 Apr;21(2):126-8. doi: 10.1097/00000421-199804000-00005. Am J Clin Oncol. 1998. PMID: 9537195

6

Late recurrence of primitive neuroectodermal tumor/medulloblastoma.

Lefkowitz IB, Packer RJ, Ryan SG, Shah N, Alavi J, Rorke LB, Sutton LN, Schut L. Lefkowitz IB, et al. Among authors: alavi j. Cancer. 1988 Aug 15;62(4):826-30. doi: 10.1002/1097-0142(19880815)62:4<826::aid-cncr2820620431>3.0.co;2-m. Cancer. 1988. PMID: 2840194

7

Phase II trial of spirogermanium and vindesine in malignant glioma.

Alavi JB, Schoenfeld D, Skeel RT, Kirkwood R, Tsung L, Marsh JC. Alavi JB, et al. Am J Clin Oncol. 1989 Feb;12(1):8-10. doi: 10.1097/00000421-198902000-00002. Am J Clin Oncol. 1989. PMID: 2912024 Clinical Trial.

8

Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trial.

Eck SL, Alavi JB, Judy K, Phillips P, Alavi A, Hackney D, Cross P, Hughes J, Gao G, Wilson JM, Propert K. Eck SL, et al. Among authors: alavi jb, alavi a. Hum Gene Ther. 2001 Jan 1;12(1):97-113. doi: 10.1089/104303401451013. Hum Gene Ther. 2001. PMID: 11177547 Clinical Trial. No abstract available.

9

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

Eck SL, Alavi JB, Alavi A, Davis A, Hackney D, Judy K, Mollman J, Phillips PC, Wheeldon EB, Wilson JM. Eck SL, et al. Among authors: alavi jb, alavi a. Hum Gene Ther. 1996 Aug 1;7(12):1465-82. doi: 10.1089/hum.1996.7.12-1465. Hum Gene Ther. 1996. PMID: 8844206 Clinical Trial.

10

Sequential computerized tomography and positron emission tomography studies in a patient with malignant glioma.

Alavi JB, Alavi A, Goldberg HI, Dann R, Hickey W, Reivich M. Alavi JB, et al. Among authors: alavi a. Nucl Med Commun. 1987 Jul;8(7):457-68. doi: 10.1097/00006231-198707000-00002. Nucl Med Commun. 1987. PMID: 2825089

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters